The deal is part of a partnership announced March 7, which connects Mark Cuban’s drug manufacturing facility in Dallas to nine hospitals owned by Franklin, Tenn.-based Community Health Systems.
“This milestone marks the beginning of our effort to tackle the national shortage and ensure essential medications are accessible at fair prices,” Cost Plus Drugs said in an April 18 post on X.
The nine hospitals also expect deliveries of norepinephrine. Both medications are manufactured in specialized vial sizes, which were designed for hospital use. This summer, the 20,000-square-foot manufacturing plant will begin producing four chemotherapies in short supply: vinblastine, cisplatin, methotrexate and dacarbazine.
CHS is currently the only health system to partner with Cost Plus Drugs.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
